🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

As stroke care gets better and better non-inferiority trials in stroke become more and more popular... Want to learn more about then and avoid some common pitfalls? check out our review just published Stroke AHA/ASA !! 🧠🧠

Latest overview by Christian Boehme on microvascular changes post-EVT and how they impact clinical outcomes 🎨 Eike Piechowiak Thomas Meinel Tomas Dobrocky David Seiffge Martina Göldlin Eva A. Mistry, MBBS, MSCI, FAHA Urs Martin Fischer Susanne Wegener Johannes Kaesmacher @shaokaizheng Stroke Research Center Bern Insel Gruppe Faculty of Medicine, University of Bern

Register today & learn the latest advances of procedural imaging in the angio suite with Johannes Kaesmacher and Gregoire Boulouis 🎨All infos on the link below ⬇️ Stroke Research Center Bern Thomas Meinel David Seiffge Urs Martin Fischer Universität Bern Faculty of Medicine, University of Bern European Stroke Org AHA Science lestudium-ias.com/events/flat-pa…

It was once again an incredible experience, bringing together neurologists and neuroradiologists in an inspiring atmosphere. We extend our heartfelt gratitude to our sponsors, faculty and, of course, our amazing participants! European Stroke Org ESMINT Society ESNR Insel Gruppe

Thanh Lam "Lance" Tran The use of anti-Xa activity cut-off of <0.5IU is not supported by any data. It was introduced in the ESO guidelines based on „expert“ opinion. Just DO-IT Trial Stroke Research Center Bern Thomas Meinel Jan Purrucker Teddy Wu Ashkan Shoamanesh Luciana Catanese, MD Aristeidis Katsanos Espen Saxhaug Kristoffersen

Congratulations Urs Martin Fischer Marios Psychogios & team! A bit hard to believe that we go from a NNT 2.6 in HERMES to no effect after the MCA furcation. We need to look at subgroups in this heterogeneous population and IPDMA of similar trials based on perfusion imaging and types of BMT.

🚨 ELAPSE Trial Alert! 🚨 The trial is now approved in Germany, with Universitätsklinikum Leipzig as the first site open for patient accrual. Huge thanks to Rolf Wachter and Dominik Michalski for their support in achieving this milestone! Lorenz Räber, MD PhD David Seiffge Urs Martin Fischer

Direct oral anticoagulants versus vitamin K antagonists for cerebral venous thrombosis (DOAC-CVT): an international, prospective, observational cohort study - The Lancet Neurology thelancet.com/journals/laneu…

EURECA: New data on recurrent ICH: every second recurrence is adjacent to index ICH. Those bleedings occur early and are strongly associated with CAA. Great collaboration lead by Martina Göldlin Stroke Research Center Bern Author interview podcast: edhub.ama-assn.org/jn-learning/au… jamanetwork.com/journals/jaman…

Patients with ischemic stroke and recent DOAC intake deserve better treatment! Let‘s DO-IT Trial ! Thomas Meinel Urs Martin Fischer Ashkan Shoamanesh Luciana Catanese, MD Aristeidis Katsanos Stroke Research Center Bern Jan Purrucker Espen Saxhaug Kristoffersen Teddy Wu UCL Stroke Research European Stroke Org Schweizerischer Nationalfonds (SNF)

New Swiss Stroke Society Position Paper on atrial fibrillation (AF) monitoring & management after ischemic stroke is out now in Swiss Medical Weekly! 🧵👇🇨🇭 🔗 DOI: doi.org/10.57187/s.4170

#TECNO is growing! We now have 26 active study sites across Europe, thanks to the incredible collaboration of our investigators. 🙌 A huge THANK YOU to all teams for your efforts in advancing stroke research and care! 💿

Randomisierte Studie der #InselGruppe, Universität Bern & UniSpitalBaselCH zeigt: Pulsed Field Ablation (PFA) verursacht weniger Rezidive als herkömmliche Katheterablation. Vielversprechende Ergebnisse für Patient:innen mit Vorhofflimmern! Mehr: inselgruppe.ch/de/aktuell/det… Faculty of Medicine, University of Bern

How do chronic ischemic lesions differ in patients with #AtrialFibrillation and #SmallVesselDisease? We compared MRIs from The ELAN Trial and #SVD cohorts: whereas AF patients had mostly cortical cerebellar lesions, SVD patients had deep lesions ahajournals.org/doi/pdf/10.116…

In den letzten Jahren hat man neue Methoden für die Akutbehandlung einer #Hirnblutung entwickelt. Für den Neurologen Urs Fischer besteht deshalb die berechtigte Hoffnung, dass Betroffene künftig unter weniger #Folgeschäden leiden. 👌 swissheart.ch/wissen-und-sup… Urs Martin Fischer

#STROKE: The topography of cerebellar ischemic lesions may inform an understanding of their underlying etiology. Anna Kopczak Marco Pasi Marco Duering Thomas Meinel Urs Martin Fischer #AHAJournals ahajrnls.org/42CwAhU

LAAO and stroke: We summarize current evidence & ongoing trials: promising option for AF patients to avoid OAC (i.e. after ICH, CAA) or if DOAC alone is not enough (i.e. after #breakthroughstroke) Alexander Benz ⁦ELAPSE⁩ ⁦Stroke AHA/ASA⁩ ahajournals.org/doi/10.1161/ST…

⏰ Regular registration for #ESOC2025 closes TOMORROW! Benefit from preferential rates and secure your place at the leading #stroke conference👉 ow.ly/ZnqA50VANRz Join us in Helsinki to connect with peers, meet mentors, and be part of a global community! #voiceofstroke

Internationale Studie zeigt: Frühzeitige Blutverdünnung nach Schlaganfall ist sicher & wirksam. Patient:innen mit Vorhofflimmern profitieren deutlich – 30 % weniger Folge-Schlaganfälle. Mehr: neurologie.insel.ch/de/aktuelles/d… #InselGruppe #Schlaganfall #Neurologie Urs Martin Fischer